New Haven Pharmaceuticals said data on the antiplatelet effects of Durlaza will be presented in a poster session during the American Heart Association Scientific Sessions that begin this weekend in Orlando, Florida. Read More »
CVS Health said Monday it will be expanding its Registered Apprenticeship program to include new markets and fields of study. Read More »
Use of prescription drugs among adults in the United States has drastically increased since the turn of the 21st century, a study published Tuesday in the Journal of the American Medical Association said. Read More »
The pharmaceutical industry is being forced to undergo an extensive transformation as the serialization of prescription medicine packages to verify the origins of a given medicine will be mandatory in all European Union countries by 2019. Read More »
Bristol-Myers Squibb has entered into a deal to acquire all issued and outstanding capital stock of Cardioxyl Pharmaceuticals, Inc. Read More »
The FDA has granted priority review of Acadia Pharmaceuticals' new drug application (NDA) for Nuplazid (pimavanserin) that is intended to treat Parkinson's disease psychosis. Read More »
The American Society of Health-System Pharmacists (ASHP) said legislation pending in the U.S. House of Representatives that would help the medically underserved needs four more co-sponsors to get to the next phase. Read More »
AstraZeneca and Eli Lilly and Co. said recently they will expand their present immuno-oncology collaboration to develop innovative combination therapy options for patients with solid tumors. Read More »
The U.S. Food and Drug Administration approved Strensiq (asfotase alfa) to treat perinatal, infantile and juvenile-onset hypophosphatasia (HPP), a rare, genetic, progressive, metabolic disease. Read More »
The U.S. Food and Drug Administration (FDA) recently approved Veltassa (patiromer for oral suspension) to treat patients with elevated levels of potassium in the blood, a condition known as hyperkalemia. Read More »
The U.S. Department of Health and Human Services Office of Inspector General said recently the federal Medicaid program could have realized savings if New York had applied medical loss ratio standards like those set in the Affordable Care Act (ACA). Read More »
Patients with high cholesterol are prescribed statins, but a recent study said about half of these patients will stop using the medication within the first year. Read More »
Cigna and Central Florida Affordable Care LLC announced on Thursday a collaboration to lower costs while improving health care and patient experience under Cigna’s accountable care organizations program called Cigna Collaborative Care. Read More »
A study of records at New York University's Langone Medical Center determined that too many patients being treated for severe acne are being left on ineffective antibiotics for too long before being prescribed isotretinoin (also known by its former brand name Accutane). Read More »
Track and Trace requirements scheduled to go into effect Sunday have been delayed until March 1, according to a Thursday announcement from the Food and Drug Administration (FDA). Read More »
Arena Pharmaceuticals Inc. has begun patient dosing in a Phase 1b multiple-ascending dose clinical trial of APD371, a selective agonist of the cannabinoid 2 (CB2) receptor. Read More »
Imlygic (talimogene laherparepvec) has become the first FDA-approved oncolytic virus therapy indicated for the treatment of melanoma lesions in the skin and lymph nodes. Read More »
PharmaEngine Inc. recently announced the U.S. Food and Drug Administration's (FDA) approval of Merimack's Onivyde (irinotecan liposome injection) in combination with fluorouracil (5-FU) and leucovorin (LV). Read More »
The American Society of Health-System Pharmacists (ASHP) recently published its annual compilation, ASHP Best Practices, featuring information such as quality policy positions, statements, guidelines, therapeutic position statements, and therapeutic and clinical practice guidelines for the pharmacy profession. Read More »
ClearPath Development Co. has partnered with Astellas Pharma Inc. to form a second vaccine company, Nosocomial Vaccine Corp. (NVC). Read More »
Alerts Sign-up
